Dual GIP/GLP-1 agonist · extended format
Tirzepatide
Dual GIP/GLP-1 action.
Extended 30 mg presentation of Tirzepatide, the dual GIP/GLP-1 agonist widely studied in research on glycemic response, appetite and body composition.
Signalis Bio Made by Signalis Bio in the USA · US labs and US-sourced materials
Made in the USA
Description
About this peptide
Extended 30 mg presentation of Tirzepatide, the dual GIP/GLP-1 agonist widely studied in research on glycemic response, appetite and body composition. Same research-grade purity, three times the content per vial.
Every Signalis Bio product is selected under research-grade quality criteria and is part of a catalog curated by our medical team specialized in longevity, backed by published studies. For responsible use, we always recommend professional guidance.
Quick facts
Areas of interest
Research focus
Glycemic response
Widely investigated for its action on glycemic response.
Appetite regulation
Observed for its action on satiety signals.
Extended format
Three times the content of the standard 10 mg vial.
Delivery
Discreet and secure delivery
Discreet packaging
No visible content labels.
International shipping
Time and cost confirmed before dispatch.
Tracking
We notify you using your order details.
Questions before buying?
Our AI advisor explains the science behind each product, compares options and guides you through the catalog. For orders and logistics, our team follows up with you.
You may also like
